Jacob Hughes
Stock Analyst at Wells Fargo
(2.26)
# 2,590
Out of 4,711 analysts
31
Total ratings
57.14%
Success rate
7.84%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jacob Hughes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AMPH Amphastar Pharmaceuticals | Maintains: Equal-Weight | $40 → $44 | $39.14 | +12.42% | 5 | May 17, 2023 | |
| PRGO Perrigo Company | Upgrades: Overweight | $54 | $25.75 | +109.71% | 1 | Sep 6, 2022 | |
| RVNC Revance Therapeutics | Maintains: Equal-Weight | $17 → $24 | $3.09 | +676.70% | 4 | Aug 25, 2022 | |
| IRWD Ironwood Pharmaceuticals | Maintains: Equal-Weight | $12 → $13 | $4.45 | +192.13% | 3 | Aug 16, 2022 | |
| MDWD MediWound | Maintains: Overweight | $49 → $56 | $16.49 | +239.60% | 1 | May 18, 2022 | |
| EBS Emergent BioSolutions | Maintains: Equal-Weight | $46 → $38 | $8.10 | +369.14% | 3 | May 4, 2022 | |
| TEVA Teva Pharmaceutical | Maintains: Equal-Weight | $12 → $11 | $22.09 | -50.20% | 11 | Jul 29, 2021 | |
| BHC Bausch Health Companies | Maintains: Equal-Weight | $18 → $17 | $7.47 | +127.58% | 3 | Oct 28, 2020 |
Amphastar Pharmaceuticals
May 17, 2023
Maintains: Equal-Weight
Price Target: $40 → $44
Current: $39.14
Upside: +12.42%
Perrigo Company
Sep 6, 2022
Upgrades: Overweight
Price Target: $54
Current: $25.75
Upside: +109.71%
Revance Therapeutics
Aug 25, 2022
Maintains: Equal-Weight
Price Target: $17 → $24
Current: $3.09
Upside: +676.70%
Ironwood Pharmaceuticals
Aug 16, 2022
Maintains: Equal-Weight
Price Target: $12 → $13
Current: $4.45
Upside: +192.13%
MediWound
May 18, 2022
Maintains: Overweight
Price Target: $49 → $56
Current: $16.49
Upside: +239.60%
Emergent BioSolutions
May 4, 2022
Maintains: Equal-Weight
Price Target: $46 → $38
Current: $8.10
Upside: +369.14%
Teva Pharmaceutical
Jul 29, 2021
Maintains: Equal-Weight
Price Target: $12 → $11
Current: $22.09
Upside: -50.20%
Bausch Health Companies
Oct 28, 2020
Maintains: Equal-Weight
Price Target: $18 → $17
Current: $7.47
Upside: +127.58%